Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria Maniero

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 28, 2025
Relapse rate following withdrawal of vedolizumab and ustekinumab in patients with inflammatory bowel disease - a multicenter retrospective controlled study. The VEDUST-EXIT StudyAhmad Albshesh, Piotr Kucha, Daniela Pugliese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World StudyDaria Maniero, Matteo Ghisa, Alessandro Bruschi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2026
Long-term effectiveness of dupilumab in eosinophilic esophagitis: Results from the DUPEOETALY StudySalvatore Oliva, Enrico Felici, Giusy Russo, et al.
European Journal of Pediatrics|May 31, 2024
Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registryPilar Navarro, Sara Feo-Ortega, Sergio Casabona-Francés, et al.
The American Journal of Gastroenterology|June 23, 2026
Dupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT RegistryEmilio J Laserna-Mendieta, Victoria Úbeda-Vargas, Edurne Amorena, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2022
Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registryEmilio José Laserna-Mendieta, Pilar Navarro, Sergio Casabona-Francés, et al.
United European Gastroenterology Journal|January 29, 2024
Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registryEmilio J Laserna-Mendieta, Pilar Navarro, Sergio Casabona-Francés, et al.
United European Gastroenterology Journal|May 17, 2022
Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT RegistryPilar Navarro, Emilio J Laserna-Mendieta, Sergio Casabona, et al.
United European Gastroenterology Journal|November 8, 2024
Sex-related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registryEmilio J Laserna-Mendieta, Sergio Casabona-Francés, Edurne Amorena, et al.
Journal of Clinical Medicine|December 17, 2024
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 28, 2025
Relapse rate following withdrawal of vedolizumab and ustekinumab in patients with inflammatory bowel disease - a multicenter retrospective controlled study. The VEDUST-EXIT StudyAhmad Albshesh, Piotr Kucha, Daniela Pugliese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World StudyDaria Maniero, Matteo Ghisa, Alessandro Bruschi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2026
Long-term effectiveness of dupilumab in eosinophilic esophagitis: Results from the DUPEOETALY StudySalvatore Oliva, Enrico Felici, Giusy Russo, et al.
European Journal of Pediatrics|May 31, 2024
Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registryPilar Navarro, Sara Feo-Ortega, Sergio Casabona-Francés, et al.
The American Journal of Gastroenterology|June 23, 2026
Dupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT RegistryEmilio J Laserna-Mendieta, Victoria Úbeda-Vargas, Edurne Amorena, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2022
Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registryEmilio José Laserna-Mendieta, Pilar Navarro, Sergio Casabona-Francés, et al.
United European Gastroenterology Journal|January 29, 2024
Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registryEmilio J Laserna-Mendieta, Pilar Navarro, Sergio Casabona-Francés, et al.
United European Gastroenterology Journal|May 17, 2022
Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT RegistryPilar Navarro, Emilio J Laserna-Mendieta, Sergio Casabona, et al.
United European Gastroenterology Journal|November 8, 2024
Sex-related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registryEmilio J Laserna-Mendieta, Sergio Casabona-Francés, Edurne Amorena, et al.
Journal of Clinical Medicine|December 17, 2024
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
Pageof 4